Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin vs Amphotericin B in Neonatal Candidiasis
NCT00815516Phase 3Terminated
- Sponsor
- Astellas Pharma
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of micafungin in invasive candidiasis, sponsored by Astellas Pharma. Started Feb 2013; status: terminated.
02
Drugs
micafungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on NCT00815516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00815516.